Emera Incorporated EMA
50.77 USD -0.20 (-0.39%)
At closeNov 11, 2026, 4:00 PM EST
50.77 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
50.33 Day range 50.83
45.27 52-week range 55.49
- YTD
- +3.11%
- 1 year
- +6.73%
News
marketbeat.com Emera Q3 Earnings Call Highlights Emera TSE: EMA reported third-quarter adjusted earnings of C$260 million and outlined a C$21.5 billion, five-year capital plan, with most of the investment directed to its Florida utilities.
gurufocus.com Vir Biotechnology Announces Primary Endpoint Met in Pivotal Phase 3 ECLIPSE 1 Trial for Elebsiran and Tobevibart in Chronic Hepatitis Delta Vir Biotechnology, Inc. (Nasdaq: VIR), today announced positive topline results from the pivotal Phase 3 ECLIPSE 1 trial evaluating monthly subcutaneous adminis
gurufocus.com Vir Biotechnology Announces Expanded Phase 2 SOLSTICE Data for Elebsiran and Tobevibart in Chronic Hepatitis Delta, Showing Deep and Sustained Viral Suppression, and Exploratory Finite Treatment Data Vir Biotechnology, Inc. (Nasdaq: VIR), today announced new, expanded data from the Phase 2 SOLSTICE trial evaluating monthly subcutaneous administration of eleb
benzinga.com Emera Sees 2026 Adjusted EPS Growth Above 5%-7% Target Range; Maintains 5%-7% Annual Adjusted EPS Growth Target Through 2030 Emera (TSX:EMA) expect to deliver 2026 adjusted EPS growth above its annual target range of 5%-7%, while maintaining its target of 5%-7% annual adjusted EPS growth through 2030.- benzinga.com Emera Q3 Adj. EPS C$0.85 Misses C$0.93 Estimate, Sales C$1.984B Miss C$2.000B Estimate Emera (TSX:EMA) reported quarterly earnings of C$0.85 per share which missed the analyst consensus estimate of C$0.93 by 8.6 percent. This is a 3.41 percent decrease over earnings of C$0.88 per share…
benzinga.com Emera Q3 Adj. EPS C$0.85 Misses C$0.93 Estimate Emera (TSX:EMA) reported quarterly earnings of $0.85 per share which missed the analyst consensus estimate of $0.93 by 8.6 percent. This is a 3.41 percent decrease over earnings of $0.88 per share…
businesswire.com Emera Reports 2026 Third Quarter Financial Results and Unveils $21.5 Billion Five-Year Capital Plan HALIFAX, Nova Scotia--(BUSINESS WIRE)--Today, November 6, 2026, Emera Inc. (“Emera”) (TSX/NYSE: EMA) reported 2026 third quarter financial results and 5-year capital and funding plans1. Third Quarter…
benzinga.com Enbridge, Moderna On Deck Friday As Demand, Vaccine Pipeline Face Test Enbridge headlines Friday’s reports, with investors weighing whether resilient pipeline utilization can offset a softer revenue comparison. Moderna, Brookfield Asset Management, Humana, Vistra, PPL,…
benzinga.com Barclays Maintains Equal-Weight on Emera, Lowers Price Target to $50 Barclays analyst Nicholas Campanella maintains Emera (NYSE:EMA) with a Equal-Weight and lowers the price target from $53 to $50.
benzinga.com Top 3 Utilities Stocks Which Could Rescue Your Portfolio This Month Deep Fission, Emera and VivoPower are oversold utilities stocks with RSI readings near or below 30, presenting potential buying opportunities.